Background and aims: Metformin, the first-line therapy for type 2 diabetes (T2D), has pleiotropic actions to lower both fasting and postprandial hyperglycaemia
Set us as preferred In the first head-to-head comparison of two blockbuster drugs used in real-world conditions, people who took Mounjaro lost significantly more weight than their counterparts who took Ozempic and the longer the patients kept taking the drugs, the wider the gap became
Apr 15 2019;11(4)doi:10.3390/nu11040850 Mehmood A, Usman M, Patil P, Zhao L, Wang C
Rinsing is strongly recommended
Beyond tangible weight loss, semaglutide facilitates noteworthy advancements in health metrics pertinent to cardiovascular diseases, strokes, and diabetes, contributing to long-range well-being enhancements
By leveraging GLP-1, it helps control appetite, burn fat more effectively, and primes the microbiome for optimal gut health